Cory Kasimov
Stock Analyst at Evercore ISI Group
(0)
# 4236
Out of 5,240 analysts
91
Total ratings
43.90%
Success rate
-8.34%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
BridgeBio Pharma | Maintains: Outperform | 45 50 | 35.51 | 40.81% | 3 | Dec 23, 2024 | |
Edgewise Therapeutic... | Maintains: Outperform | 45 50 | 27.55 | 81.49% | 2 | Dec 17, 2024 | |
SpringWorks Therapeu... | Initiates Coverage On: Outperform | 60 | 32.49 | 84.67% | 1 | Nov 20, 2024 | |
BioNTech | Upgrades: Outperform | 110 125 | 112.44 | 11.17% | 4 | Nov 19, 2024 | |
Biomarin Pharmaceuti... | Maintains: Outperform | 115 105 | 63.78 | 64.63% | 10 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 1250 1175 | 690.23 | 70.23% | 5 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: In-Line | 120 120 | 34.47 | 248.13% | 4 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 85 | 64.58 | 31.62% | 1 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 175 | 139.49 | 25.46% | 1 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 84 88 | 40.11 | 119.4% | 5 | Feb 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 260 250 | n/a | n/a | 2 | Jun 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 50 | n/a | n/a | 1 | Jan 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 324 276 | 143 | 93.01% | 3 | Dec 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 35 | 3.63 | 864.19% | 1 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 1520 780 | 8.03 | 9613.57% | 3 | Feb 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 225 232 | 267 | -13.11% | 5 | Jul 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 4 | May 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 1 | May 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 168 163 | n/a | n/a | 2 | Apr 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 25 21 | 28.5 | -26.32% | 2 | Feb 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | n/a | n/a | n/a | 4 | Nov 14, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 83 23 | 3.08 | 646.75% | 6 | Nov 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 71 16 | n/a | n/a | 8 | Oct 31, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 60 63 | n/a | n/a | 5 | May 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Overweight | 110 | n/a | n/a | 2 | Mar 21, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | n/a | n/a | n/a | 4 | Feb 14, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 15 10 | 0.69 | 1349.28% | 1 | Feb 14, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 310 250 | 12.47 | 1904.81% | 1 | Feb 14, 2018 |